<DOC>
	<DOCNO>NCT02835560</DOCNO>
	<brief_summary>This study compare efficacy safety Ilaprazole base bismuth-containing quadruple regimen therapy include Ilaprazole 5mg , Bismuth Potassium Citrate 220mg , Clarithromycin 500mg Amoxicillin Cap ( Amoxicillin ) 1000mg BID first line eradication treatment H.pylori . Participants define person endoscopically confirm gastric duodenal ulcer ( include scar stage ) , gastritis dyspepsia confirm H.pylori positive patient biopsy UBT test . For 14 day , participant treat Esoprazole base bismuth-containing quadruple regimen therapy therapy include Esoprazole 20mg , Bismuth Potassium Citrate 220mg , Clarithromycin 500mg Amoxicillin Cap ( Amoxicillin ) 1000mg BID . After treatment , heal rate evaluate UBT test Biopsy 49±5days first day dosing .</brief_summary>
	<brief_title>Efficacy Safety Ilaprazole Based Bismuth-containing Quadruple Regimen First-line Treatment Helicobacter Pylori Infection</brief_title>
	<detailed_description>This study compare efficacy safety Ilaprazole base bismuth-containing quadruple regimen therapy include Ilaprazole 5mg , Bismuth Potassium Citrate 220mg，Clarithromycin 500mg Amoxicillin Cap ( Amoxicillin ) 1000mg BID first line eradication treatment H.pylori . Participants define person endoscopically confirm gastric duodenal ulcer ( include scar stage ) , gastritis dyspepsia confirm H.pylori positive patient biopsy UBT test . For 14 day , Participants treat Esoprazole base bismuth-containing quadruple regimen therapy therapy include Esoprazole 20mg , Bismuth Potassium Citrate 220mg，Clarithromycin 500mg Amoxicillin Cap ( Amoxicillin ) 1000mg BID . After treatment , The heal rate evaluate UBT test Biopsy 49±5days first day dosing .</detailed_description>
	<mesh_term>Helicobacter Infections</mesh_term>
	<mesh_term>Bismuth</mesh_term>
	<mesh_term>Potassium Citrate</mesh_term>
	<criteria>Subject must endoscopically confirm gastric , duodenal ulcer ( include scar ) gastritis confirm H.pylori positive patient biopsy UBT test . Subject fully understand condition clinical trial . Subject agree participate spontaneously sign ICF . Known hypersensitivity component ilaprazole , Amoxicillin Levofloxacin . Subjects take contraindicated medication experimental concomitant drug . Patients abnormal level laboratory test . Total Bilirubin , Creatinine &gt; 1.5 time upper limit normal . AST , ALT , Alkaline phosphatase , BUN &gt; 2 time upper limit normal . Administrated PPI , antibiotic medication within 4 week prior commencement study . Pregnant and/or lactate woman . Reproductive age woman use contraception . Uncontrolled diabetic . Uncontrolled hypertension . Uncontrolled liver dysfunction .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>June 2012</verification_date>
</DOC>